Literature DB >> 3959497

Lipid abnormalities in plasma and red cell membranes of chronic alcoholics.

M R Clemens, H W Schied, W Daiss, H D Waller.   

Abstract

The fatty acid composition of plasma and red cell membranes was determined in alcoholics without liver dysfunction upon admission for withdrawal therapy and after a 4-week period of abstinence, and in normal subjects. Fatty acid analysis of plasma by capillary gas chromatography showed a higher proportion of saturated fatty acids in alcoholics on admission than in normal subjects. Other major differences in plasma fatty acids in alcoholics were the reduction of linoleic acid and the increase in palmitic acid. Similar abnormalities were measured in red cell membranes of alcoholics. Although there were less polyunsaturated fatty acids in red cells of alcoholics, the degree of hydrogen peroxide or phenylhydrazine-induced lipid peroxidation was the same as in controls. Membrane tolerance to ethanol was attributed to adaptive membrane alterations (increase of saturated fatty acids in membranes). However, the here reported changes in plasma and red cell lipids suggest that alterations in red cell membrane lipids reflect abnormalities in plasma lipids due to equilibrium exchanges rather than signify adaptive changes of the red cells to ethanol.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3959497     DOI: 10.1007/bf01713460

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  31 in total

1.  Could superoxide cause cirrhosis?

Authors:  K O Lewis; A Paton
Journal:  Lancet       Date:  1982-07-24       Impact factor: 79.321

2.  Effect of ethanol administration on fatty acid desaturation.

Authors:  A M Nervi; R O Peluffo; R R Brenner; A I Leikin
Journal:  Lipids       Date:  1980-04       Impact factor: 1.880

3.  Ethanol-induced fluidization of brain lipid bilayers: required presence of cholesterol in membranes for the expression of tolerance.

Authors:  D A Johnson; N M Lee; R Cooke; H H Loh
Journal:  Mol Pharmacol       Date:  1979-05       Impact factor: 4.436

4.  Effects of chronic ethanol treatment on lipid composition and prostaglandins in rats fed essential fatty acid deficient diets.

Authors:  C Alling; W Becker; A W Jones; E Anggärd
Journal:  Alcohol Clin Exp Res       Date:  1984 Mar-Apr       Impact factor: 3.455

5.  Changes in relative levels of linoleate to arachidonate in erythrocyte phosphatidylcholine in rats fed ethanol and arachidonate.

Authors:  G A Rao; S C Goheen; E C Larkin
Journal:  Toxicol Lett       Date:  1981-03       Impact factor: 4.372

6.  Enhanced ratio of linoleic acid to arachidonic acid in erythrocyte phosphatidylcholine in rats during withdrawal from ethanol.

Authors:  G A Rao; S C Goheen; M Manix; E C Larkin
Journal:  Toxicol Lett       Date:  1980-11       Impact factor: 4.372

7.  Decreased erythrocyte membrane fluidity and altered lipid composition in human liver disease.

Authors:  J S Owen; K R Bruckdorfer; R C Day; N McIntyre
Journal:  J Lipid Res       Date:  1982-01       Impact factor: 5.922

8.  Phenylhydrazine-induced lipid peroxidation of red blood cells in vitro and in vivo: monitoring by the production of volatile hydrocarbons.

Authors:  M R Clemens; H Remmer; H D Waller
Journal:  Biochem Pharmacol       Date:  1984-06-01       Impact factor: 5.858

9.  Increased cholesterol content of erythrocyte and brain membranes in ethanol-tolerant mice.

Authors:  J H Chin; L M Parsons; D B Goldstein
Journal:  Biochim Biophys Acta       Date:  1978-11-16

10.  The fatty acid composition of red cells deficient in glucose-6-phosphate dehydrogenase and their susceptibility to lipid peroxidation.

Authors:  M R Clemens; H Einsele; H D Waller
Journal:  Klin Wochenschr       Date:  1985-07-01
View more
  1 in total

1.  Alcohol consumption and hepatic fibrosis affect the fatty acid composition of red blood cells and their susceptibility to lipid peroxidation.

Authors:  M R Clemens; H Einsele; H Remmer
Journal:  Arch Toxicol       Date:  1987       Impact factor: 5.153

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.